Clinical trial NCT03803735: Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa
Official title: French African Pediatric Oncology Registry
Study type: OBSERVATIONAL
Overall status: RECRUITING
Conditions: Pediatric Cancer
Lead sponsor: French Africa Pediatric Oncology Group
Sponsor class: OTHER
Collaborators: name: Gustave Roussy, Cancer Campus, Grand Paris
First posted: 2019-01-15
Enrollment: 10000
Sex: ALL
Minimum age (years): 1
Maximum age (years): 18
Standard ages: CHILD
ADULT
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: All childre with any pediatric cancer types, coming into any one of the participating units in a 12 month period.

Brief summary: The ultimate aim of this registry is to collect precise information concerning the children coming to oncology units working with the French African Oncology Group. This data will help to plan and provide correct pediatric oncology treatment and care for this population.

Collecting the data will give much needed information on numbers, stage, treatment and outcome. The register will give data for local and national health authorities in planning pediatric cancer programs.

Detailed description: This register is a registration of all children entering hospital based pediatric oncology units, working in selected hospitals in French speaking Africa. The data collected includes: demographic and socioeconomic status as well as clinical status and outcome.

The register also collects information on vital status, treatment abandonment and loss to follow-up.

Data, collected locally is entered on line using the Research Electronic Data Capture (REDCap) program. Data are stored under the responsibility of the IT department at Gustave ROUSSY in Paris- Villejuif.

Eligibility criteria: Inclusion Criteria:

1. Any child presenting at any one of the participating units for treatment
2. Any child with any type of cancer
3. Any child or adolescent less than 18 years of age.

Exclusion Criteria:

1. No cancer found
2. Age greater than 18 years -

Primary outcomes:
measure: Number of children with a suspicion of any type of cancer in a given unit
timeFrame: in any 12 month period
measure: VITAL STATUS:
timeFrame: in any 12 month period
measure: Illness status
timeFrame: in any 12 month period
measure: Treatment Status
timeFrame: in any 12 month period
Secondary outcomes:
Other outcomes:
Locations:
city: Ouagadougou
country: Burkina Faso
facility: Hopital Yalgado Ouedraogo
city: Ouagadougou
country: Burkina Faso
facility: Centre Hospitalier Universitaire Pédiatrique Charles De Gaulle
city: Yaoundé
country: Cameroon
facility: Centre Mère et Enfant CME-FCB (Fondation Chantal Biya)
city: Kinshasa
country: Congo, The Democratic Republic of the
facility: Cliniques Universitaires de Kinshasa
city: Lubumbashi
country: Congo, The Democratic Republic of the
facility: Cliniques Universitaires de Lubumbashi (CUL)
city: Abidjan
country: Côte D'Ivoire
facility: CHU de Treichville à ABIDJAN
city: Villejuif
country: France
facility: GFAOP
state: Paris
city: Libreville
country: Gabon
facility: l'Institut de Cancérologie de Libreville
city: Antananarivo
country: Madagascar
facility: HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona
state: Ampefiloha
city: Bamako
country: Mali
facility: CHU Gabriel Touré (HGT)
city: Nouakchott
country: Mauritania
facility: Centre National d'Oncologie (CNO)
city: Niamey
country: Niger
facility: CNLC, Centre National de Lutte contre le Cancer
city: Dakar
country: Senegal
facility: Hôpital Aristide Le Dantec, Avenue Pasteur, BP 3001
city: Lomé
country: Togo
facility: CHU Sylvanus Olympio
Study officials:
affiliation: French Africa Pediatric Oncology Group
name: Brenda Mallon, MSc
role: STUDY_DIRECTOR
References: